skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Find out which market-moving events and catalysts to watch for during the upcoming Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

During this webinar recording, industry analysts from Informa Pharma Intelligence  present their data-based views on what’s in store for key drugs in early 2019.  Discussion include important upcoming events related to these key drugs, their likelihood of phase/PDUFA review success and likelihood of approval, and an examination of the market significance of the drugs themselves.

Presented by:

  • Michael Haydock, Therapeutic Area Director for Cardiovascular and Metabolic, and Infectious Diseases, Datamonitor Healthcare and Biomedtracker
  • Dominique Fontanilla, Therapeutic Area Director, CNS and Immunology and Inflammation, Datamonitor Healthcare and Biomedtracker
  • Hardik Patel, Therapeutic Area Director, Oncology and Respiratory, Datamonitor Healthcare and Biomedtracker


Highlights include:

  • The significance of key drugs mentioned in the Early 2019 Outlook Report
  • Top-line trial results, pivotal trial initiations, and expected regulatory filings, reviews, and approvals
  • Likelihood of Phase/PDUFA review success, overall Likelihood of Approval, and sales potential of key therapies

Download webinar slides


Read also

  • Biomedtracker: see the drug development process through anal...

    Key Potential Drug Launches in 2022

    Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.

  • Biomedtracker: see the drug development process through anal...

    2020 Deal-Making Roundup

    Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

    Topics Drug Review Coronavirus

  • Biomedtracker: see the drug development process through anal...

    Q3 2021 Outlook Report

    What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

    Topics Drug Review

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: